Approvals/TGA/JULUCA dolutegravir (as sodium) 50 mg/ rilpivirine (as hydrochloride) 25 mg tablet bottle

Approved

STANDARD

JULUCA dolutegravir (as sodium) 50 mg/ rilpivirine (as hydrochloride) 25 mg tablet bottle

ViiV Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: cea0bda22d26b282
Product Name: JULUCA dolutegravir (as sodium) 50 mg/ rilpivirine (as hydrochloride) 25 mg tablet bottle
Artg Id: 291356
Artg Name: JULUCA dolutegravir (as sodium) 50 mg/ rilpivirine (as hydrochloride) 25 mg tablet bottle
Sponsor: ViiV Healthcare Pty Ltd
Company Detail Path: /organization/viiv-healthcare-pty-ltd
Artg Date: 2018-06-20
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/d41679c5e83359825864553f412f5a10.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/b41d1bf46ffbab19ca0a1cc5753bdb69.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

cea0bda22d26b282

Type

Standard